Reuters reported last week that U.S. courts would start to hear cases against Boehringer Ingelheim over its stroke prevention pill Pradaxa (dabigatran) in August. The manufacturer is facing more than 2,000 lawsuits in the U.S. over claims the

Have you suffered pain because of a defective transvaginal mesh implant? Has your sex life been interrupted because an implant has made it difficult to have intercourse? Transvaginal mesh (TVM) implants have been linked to recurrent pelvic

According to WEWS-TV, Pradaxa (dabigatran) is the most complained about drug in the United States. The television station reported that more complaints were filed with the U.S. Food and Drug Administration (FDA) about Pradaxa than any other

Last week, the Pittsburgh Post-Gazette reported that “despite major advances in research, between 30 and 40 percent of all people diagnosed with depression don’t respond to standard treatments.” According to the Post-Gazette, the failure rate for depression treatment is

Several media outlets are reporting that Boehringer Ingelheim has received approval from the US Food and Drug Administration (FDA) for Pradaxa use to treat venous thromboembolism (VTE), which includes both deep venous thrombosis (DVT) and

According to the Institute for Safe Medication Practices (ISMP), in 2012 the US Food and Drug Administration (FDA) Adverse Event Reporting System received more than 3,200 reports of problems associated with the drug Pradaxa. Pradaxa is

LawyersandSettlements.com had an interesting story last month about the anti-seizure medications Depacon, Depakote, Depakote CP, Depakote ER, Depakene or Stavzor. According to the website, doctors now have to reconsider whether to prescribe the drugs, in light of their link to cognitive

According to Reuters, lawmakers in Massachusetts have blocked sales of Zogenix’s controversial painkiller Zohydro. The drug has been plagued with controversy, as some advocates say that it could lead to a wave of opioid abuse

Although using better outcomes for patients, there are concerns that the device may spread cancer, says The Journal of the American Medical Association. Does the FDA discourage Physicians From Using Power Morcellation for Hysterectomies? It is believed

Last fall, the US Food and Drug Administration (FDA) announced that power morcellators would receive a “black box” warning, the strongest caution the agency issues. Power morcellators are used in laparoscopic myomectomy and hysterectomy surgeries, and have